2011
DOI: 10.1016/j.bbrc.2011.02.113
|View full text |Cite
|
Sign up to set email alerts
|

Augmented oxygen-mediated transcriptional activation of cytochrome P450 (CYP)1A expression and increased susceptibilities to hyperoxic lung injury in transgenic mice carrying the human CYP1A1 or mouse 1A2 promoter in vivo

Abstract: Supplemental oxygen administration is frequently administered to preterm and term infants having pulmonary insufficiency. However, hyperoxia contributes to the development of bronchopulmonary dysplasia (BPD) in premature infants. Cytochrome P450 (CYP)A enzymes have been implicated in hyperoxic lung injury. In this study, we tested the hypothesis that hyperoxia induces CYP1A1 and 1A2 enzymes by transcriptional activation of the corresponding promoters in vivo, and transgenic mice expressing the human CYP1A1 or … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
10
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 13 publications
(12 citation statements)
references
References 34 publications
1
10
1
Order By: Relevance
“…CoQ 1 and CoQ 1 H 2 have been reported to undergo phase I and II reactions, respectively, and cytochrome P-450 1A expression is increased in the hyperoxiaexposed mouse lung (8,15,33). However, the present study ruled out such irreversible hydroxylation or conjugation reactions as explanations for the difference between CoQ 1 redox metabolism in room air-and hyperoxia-exposed lungs.…”
Section: Discussioncontrasting
confidence: 70%
“…CoQ 1 and CoQ 1 H 2 have been reported to undergo phase I and II reactions, respectively, and cytochrome P-450 1A expression is increased in the hyperoxiaexposed mouse lung (8,15,33). However, the present study ruled out such irreversible hydroxylation or conjugation reactions as explanations for the difference between CoQ 1 redox metabolism in room air-and hyperoxia-exposed lungs.…”
Section: Discussioncontrasting
confidence: 70%
“…Oxidative stress can induce protective or adverse cellular responses in a dose-dependent manner. CYP1A1 is a phase I metabolic enzyme that plays an important role in the production of ROS during the metabolism of numerous exogenous and endogenous compounds [41], [42]. Lower oxidative stress level induces cytoprotective responses, phase II drug metabolizing enzymes and antioxidant, such as GSTT1 and GSH, are involved in the elimination of ROS [43], [44].…”
Section: Discussionmentioning
confidence: 99%
“…Some of the major enzymatic sources of ROS and RNS include flavoproteins that produce H 2 O 2 , and xanthine oxidase and the nitric oxide synthases that produce O 2 •− and NO • [ 3 – 5 ]. A number of other important cellular enzymes such as Nicotinamide Adenine Dinucleotide Phosphate (NADPH) oxidase, lipooxygenases, uncoupled endothelial nitric oxide synthase (eNOS), and cytochrome P450, contribute to the production of ROS/RNS that play a role in lung diseases [ 6 9 ]. Non-enzymatic production of reactive species also occurs through metal-catalyzed oxidation such as the Fenton reaction (Fe 2+ + H 2 O 2 → Fe 3+ + OH − + OH • ) or thermodynamic reactions of NO • with O 2 •− to form peroxynitrite (ONOO − ) [ 10 , 11 ].…”
Section: Overview Of Ros/antioxidants In the Lungmentioning
confidence: 99%